Sepsis Flashcards
Definition
Sepsis
life-threatening organ dysfunction caused by a dysregulated host response to infection
Definitions
Sepsis-3 (2016)
Sepsis
life-threatening organ dysfunction caused by a dysregulated host response to infection
Clinical variables
qSOFA Score
non-ICU patients
SBP ≤ 100
Altered mental status (GCS ≤ 15)
RR ≥ 22
qSOFA >= 2 indicates sepsis
Definition
Sepsis-3 (2016)
Septic shock
Definition: A subset of sepsis in which underlying circulatory/cellular/metabolic abnormalities are profound enough to substantially increase mortality
Clinical criteria
Sepsis-3 (2016)
Septic shock
-
persistant hypotension requiring vasopressors to maintain MAP >= 65 –> cirulatory dysfunction
AND - serum lactate level >2 mmol/L –> cellular dysfunction
Clinical criteria
Sepsis-3 (2016)
Sepsis
2 or more SOFA (ICU patients)
2 or more qSOFA (non-ICU patients)
Clinical values
SOFA Score
ICU patients
PaO2/FiO2
Platelet, bilirubin
MAP (pressor requirements)
Glasgow Coma Scale (GCS)
SCr/UO
2 or more SOFA –> sepsis
Initial resuscitation
Hour-1 Bundle
Elements to be initiated within the first hour
- measure lactate level; re-measure if initial lactate is >2 mmol/L
- Obtain blood cultures prior to administration of antibiotics (aneanerobic AND aerobic)
- Administer braod spectrum abx
- Administer 30mL/kg cystalloid for hypotension ot lactate >= 4 mmol/L
- apply vasopressors if patient is hypotensive during OR after fluid resuscitation to maintain mean arterial pressure >= 65mmHg
Management of Septic Shock
- control infection
- hemodynamic stability
- other supportive measures
Management of Septic Shock
Hemodynamic stability
Fluid resuscitation
Begin immediately (within 1 hr)
- first line: crystalloids 30 mg/kg BOLUS
* NS > LR - colloids
* may consider albumin in addition to crystalloid
* avoid HES
Management of Septic Shock
Hemodynamic stability
Vasopressors - for fluid-refractory hypoperfusion
Goal: MAP of 65
- first-line: norepi
* titrate to MAP - second-line: vasopressin
* can be added to NE up to 0.03u/min IV infusion
* used to rach target MAP or dec NE usage - second-line: epinephrine
* can be added to NE
* titrate to goal MAP
* used to reach target MAP - Dopamine
* alternative to NE ONLY in patients with compromised systolic function and low risk of tachyarrythmias - dobutamine
* use if persistent hypoperfusion despite fluid/vasopressor agents - phenylephrine
* limit use
Management of septic shock: hemodynamic stability
Norepinephrine
Vasopressor, MOA
agonist
a1 > b1
Inc SVR, HR, contractility
Management of septic shock: hemodynamic stability
Epinephrine
Vasopressor, MOA
agonist
b1 > b2 > a1 > a2
Inc HR, contractility
Vasodilation, bronchodilation
Management of septic shock: hemodynamic stability
Vasopressin
Vasopressor, MOA
agonist
V123R
Inc SVR, PVR
Plt aggregation, anti-duiresis
Effective in acidosis
Management of septic shock: hemodynamic stability
Phenylephrine
Vasopressor, MOA
pure a agonist
Inc SVR
No effect on HR or contractility
Management of septic shock: hemodynamic stability
Dopamine
inotrope, MOA
Dose-dependent agonist (mcg/kg/hr)
1-5 –> DA
5-10 –> b
10-20 –> a
b –> inc HR, contractility
a –> SVR
Management of septic shock: hemodynamic stability
Dobutamine
inotrope, MOA
agonist
b1 > b2
Inc HR, contractility
Mild dec SVR and P(pulmonary)VR
Management of septic shock: hemodynamic stability
Milrinone
inotrope, MOA
inhibitor
PDE-3
Inc HR, contractility
Mild dec SVR and P(pulmonary)VR
Effective in b-blockade, little effect on HR
Management of septic shock
Other supportive measures
- corticosteroids
- bicarbs
- blood products
- glucose control
- VTE ppx
- stress ulcer ppx
Management of septic shock: other treatments
Corticosteroids
indication, meds
If fractory to fluids AND vasopressors…
Hydrocortisone 200mg/d IV
* ACTH test not reommended
taper once patient does not require vasopressors
Management of septic shock: other treatments
Bicarb
indication, pathophysio
pathophysio: hypoperfusion induces lactic acidosis
indication: pH =< 7.15
Management of septic shock: other treatments
Blood products
indication, medications
Indication: after hypoperfusion has resolved
1. RBC - if Hgb < 7, goal 7-9
2. frozen fresh plasma (FFP) - if bleeding/invasive procesures
3. plt - give if plt < 20,000 AND significant risk of bleeding OR plt < 10,000 BUT not bleeding
erythropoetin (e.g. epogen), antithrombin not recommended
Management of septic shock: other treatments
Glucose control
indication, meds, goal, monitoring
Insulin
indication: BG >180 x2 during hospital
goal: upper level BG <180
check BG q1-2hrs until glucose/inf rates are stable, then q4hrs
Management of septic shock: other treatments
VTE ppx
indication, meds, contraindications
rationale: hemodynamically unstable pts have risk of fatal PE/DVT
DOC: LMWH (unless CrCl <30 –> UFH)
Recommended unless contraindicated
Contraindications: thrombocytopenia, severe coagulopathy, active bleeding, recent intracerebral hemorrhage
If contraindicated –> mechanical ppx (e.g. compression devices, socks)
Management of septic shock: other treatments
Stress ulcer ppx
indication, meds
Indication: pts who have inc risk of bleeding during hospital
RF: coagulopathy, mechanical vent >= 48hrs, hypotension
- PPI (pantoprazole)
- H2RA (famotidine)
Clinical criteria
SIRS
SIRs >= 2
WBC > 12k or < 4k or > 10% immature bands
HR > 90
RR > 20
T > 38 or < 36